Literature DB >> 30891752

Big heart, no longer a big problem: using catecholamine-based quantifications may be an effective means to prescribe exercise to non-obstructive hypertrophic cardiomyopathy patients.

Steven Spector1, Ryan Debi1, Jin Shin1.   

Abstract

Entities:  

Keywords:  Cardiovascular Physiology; Catecholamines; Exercise Physiology

Year:  2019        PMID： 30891752      PMCID： PMC6488011          DOI： 10.1113/JP277970

Source DB:  PubMed          Journal:  J Physiol        ISSN： 0022-3751            Impact factor:   5.182


× No keyword cloud information.
  9 in total

1.  2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Bernard J Gersh; Barry J Maron; Robert O Bonow; Joseph A Dearani; Michael A Fifer; Mark S Link; Srihari S Naidu; Rick A Nishimura; Steve R Ommen; Harry Rakowski; Christine E Seidman; Jeffrey A Towbin; James E Udelson; Clyde W Yancy
Journal:  Circulation       Date:  2011-11-08       Impact factor: 29.690

2.  Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology.

Authors:  Barry J Maron; James E Udelson; Robert O Bonow; Rick A Nishimura; Michael J Ackerman; N A Mark Estes; Leslie T Cooper; Mark S Link; Martin S Maron
Journal:  J Am Coll Cardiol       Date:  2015-11-02       Impact factor: 24.094

3.  Catecholamine response to exercise in patients with non-obstructive hypertrophic cardiomyopathy.

Authors:  Ankit B Shah; Mary Z Bechis; Marcel Brown; Jennifer Michaud Finch; Garrett Loomer; Erich Groezinger; Rory B Weiner; Meagan M Wasfy; Michael H Picard; Michael A Fifer; Gregory B Lewis; Aaron L Baggish
Journal:  J Physiol       Date:  2019-01-09       Impact factor: 5.182

Review 4.  Aerobic exercise conditioning: a nonpharmacological antiarrhythmic intervention.

Authors:  George E Billman
Journal:  J Appl Physiol (1985)       Date:  2002-02

5.  The measurement of plasma catecholamine and lactate thresholds: a comparison of methods.

Authors:  T McMorris; J Sproule; S Draper; R Child; J R Sexsmith; C D Forster; J Pattison
Journal:  Eur J Appl Physiol       Date:  2000-07       Impact factor: 3.078

6.  Effect of Moderate-Intensity Exercise Training on Peak Oxygen Consumption in Patients With Hypertrophic Cardiomyopathy: A Randomized Clinical Trial.

Authors:  Sara Saberi; Matthew Wheeler; Jennifer Bragg-Gresham; Whitney Hornsby; Prachi P Agarwal; Anil Attili; Maryann Concannon; Annika M Dries; Yael Shmargad; Heidi Salisbury; Suwen Kumar; Jonathan J Herrera; Jonathan Myers; Adam S Helms; Euan A Ashley; Sharlene M Day
Journal:  JAMA       Date:  2017-04-04       Impact factor: 56.272

Review 7.  Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases.

Authors:  Barry J Maron; Bernard R Chaitman; Michael J Ackerman; Antonio Bayés de Luna; Domenico Corrado; Jane E Crosson; Barbara J Deal; David J Driscoll; N A Mark Estes; Claudio Gil S Araújo; David H Liang; Matthew J Mitten; Robert J Myerburg; Antonio Pelliccia; Paul D Thompson; Jeffrey A Towbin; Steven P Van Camp
Journal:  Circulation       Date:  2004-06-08       Impact factor: 29.690

Review 8.  Exercise-Induced Cardiac Remodeling: Lessons from Humans, Horses, and Dogs.

Authors:  Rob Shave; Glyn Howatson; Dave Dickson; Lesley Young
Journal:  Vet Sci       Date:  2017-02-12

9.  Clinical Outcomes in Patients With Nonobstructive, Labile, and Obstructive Hypertrophic Cardiomyopathy.

Authors:  Dai-Yin Lu; Iraklis Pozios; Bereketeab Haileselassie; Ioannis Ventoulis; Hongyun Liu; Lars L Sorensen; Marco Canepa; Susan Phillip; M Roselle Abraham; Theodore P Abraham
Journal:  J Am Heart Assoc       Date:  2018-02-25       Impact factor: 5.501
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.